CHD1 and posterior cortical atrophy: From a clinical perspective, the loss of CHD1 has been found to correlate with higher Gleason grade, tumor stage, and postoperative biochemical relapse (BCR) in a cohort of more than 2000 PCa patients and suggested as a predictor for poor prognosis [6].